drugset / Trial / NCT01563081
Safety Study of Levocetirizine Oral Solution for Japanese Pediatrics
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety of treatment with levocetirizine oral solution in pediatric patients aged form 6 months to 2 years old with allergic rhinitis or pruritus associated with the skin diseases.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levocetirizine | Unknown | 1.25 mg | Oral |